Agilent Technologies, Inc. (A) vs Regeneron Pharmaceuticals, Inc. (REGN)
REGN leads on 13 of 16 compared metrics.
A side-by-side comparison of Agilent Technologies, Inc. and Regeneron Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 14, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
A
Agilent Technologies, Inc.
$129.84Healthcare
REGN
Regeneron Pharmaceuticals, Inc.
$612.14Healthcare
Total return — A vs REGN
growth of $100 · last 27yA +350.8%REGN +6895.9%REGN compounded faster
Log scale — wide-divergence pair
A REGN
A vs REGN: by the numbers
- •REGN is the larger company ($63.06B vs $36.67B market cap).
- •REGN trades at the lower earnings multiple (14.92 vs 26.07 P/E).
- •REGN converts more revenue to profit (29.65% vs 19.55% net margin).
- •REGN grew revenue faster over the past five years (10.16% vs 4.45% CAGR).
- •REGN pays the higher dividend yield (0.59% vs 0.58%).
Which is better, A or REGN?
Metric tally: A 3 · REGN 13It depends on what you're optimizing for:
ValueREGN(lower P/E)
GrowthREGN(faster 5Y revenue CAGR)
QualityA(higher ROIC)
Valuation
| Metric | A | REGN |
|---|---|---|
| P/E ratio | 26.07 | 14.92● |
| Forward P/E | 19.69 | 11.30● |
| P/S ratio | 5.10 | 4.42● |
| P/B ratio | 5.18 | 2.10● |
| PEG ratio | 9.41 | 3.38● |
| EV / EBITDA | 19.58 | 11.43● |
| FCF yield | 3.41% | 6.30%● |
Profitability
| Metric | A | REGN |
|---|---|---|
| Gross margin | 53.00% | 84.55%● |
| Operating margin | 21.50% | 24.32%● |
| Net margin | 19.55% | 29.65%● |
| ROE | 19.85%● | 14.08% |
| ROIC | 12.57%● | 8.51% |
Dividends
| Metric | A | REGN |
|---|---|---|
| Dividend yield | 0.58% | 0.59% |
| Payout ratio | 16.36% | 8.45% |
Growth (annualized)
| Metric | A | REGN |
|---|---|---|
| Revenue CAGR (5Y) | 4.45% | 10.16%● |
| EPS CAGR (5Y) | 14.52%● | 5.70% |
| FCF CAGR (5Y) | 0.05% | 15.42%● |
| Total return CAGR (5Y) | -1.34% | 3.26%● |
Frequently asked
- Which is better, A or REGN?
- It depends on your goal. value: REGN (lower P/E); growth: REGN (faster 5Y revenue CAGR); quality: A (higher ROIC). Across all compared metrics, REGN leads 13 to 3.
- Is A or REGN cheaper?
- On trailing earnings, REGN is cheaper: A trades at a 26.07 P/E and REGN at 14.92.
- Which has grown faster, A or REGN?
- Over the past five years, REGN grew revenue faster — A at a 4.45% CAGR versus REGN at 10.16%.
- Does A or REGN pay a bigger dividend?
- A yields 0.58% and REGN yields 0.59% based on trailing dividends and the latest price.
- Is A or REGN more profitable?
- REGN runs the higher net margin — A at 19.55% versus REGN at 29.65%.
- Which has been the better investment, A or REGN?
- Over the past 10-year, A delivered the higher annualized total return — A at 11.94% versus REGN at 5.19%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Agilent Technologies P/E ratioRegeneron Pharmaceuticals P/E ratioAgilent Technologies dividend yieldRegeneron Pharmaceuticals dividend yieldAgilent Technologies ROERegeneron Pharmaceuticals ROEAgilent Technologies operating marginRegeneron Pharmaceuticals operating marginAgilent Technologies revenue growthRegeneron Pharmaceuticals revenue growthAgilent Technologies free cash flowRegeneron Pharmaceuticals free cash flow
Agilent Technologies & Regeneron Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 14, 2026.